Shares in Abbott (NYSE:ABT) fell today after the medical device maker beat expectations on Wall Street but saw profits shrink in its first quarter earnings release. The Abbott Park, Ill.-based company posted profits of $418 million, or 23¢ per share, on sales of approximately $7.4 billion for the three months ended March 31, seeing the bottom […]
How these Boston Marathon runners kept their diabetes in check with Abbott’s FreeStyle Libre monitor
When Courtney Duckworth was first diagnosed with Type I diabetes, her glucometer was the size of a cell phone and she pricked her fingers nearly 12 times each day to keep track of her blood sugar. “I couldn’t feel the things that I touched because I had so many scabs,” she told Drug Delivery Business News. […]
Abbott releases cybersecurity, battery update for high-voltage implantable cardiac devices
Abbott (NYSE:ABT) today announced a firmware upgrade for its high-voltage implantable cardiac devices looking to shore up cybersecurity and improve battery performance. The company stated that while the update is intended to improve cybersecurity through an additional layer of protection against unauthorized device access, it has not received any reports that any of its devices have been […]
Asahi Intecc to begin direct sales of PCTA guidewires
Asahi Intecc said today it plans to begin direct sales of its coronary percutaneous transluminal coronary angioplasty guidewires in the US, which are currently only distributed by Abbott‘s (NYSE:ABT) vascular division. The shift will take place on July 1, at which time Asahi’s entire portfolio of PTCA guidewires will be available directly from it, the […]
Abbott launches study comparing OCT to angiography in stent placement procedures
Abbott (NYSE:ABT) today announced the launch of new trial exploring long-term outcomes in patients who underwent stent implantation guided by optical coherence tomography as compared to angiography. The first patient in the trial was enrolled by Dr. Franco Fabbiocchi at Milan, Italy’s IRCCS Centro Cardiologico, the Abbot Park, Ill.-based company said. “Today, most of the world […]
Abbott disputes ‘flawed and inaccurate’ proxy report over CEO’s pay
Abbott (NYSE:ABT) this week disputed a proxy statement made by Institutional Shareholder Services, saying it posed “incorrect, unreliable voting recommendations” related to executive compensation and a separation of the board chair and CEO positions, which are slated to be voted on at the company’s upcoming annual shareholder meeting. The company said that ISS was aware that their […]
Sunrise Labs executes succession plan | Personnel Moves – April 5, 2018
Medical device and life science development group Sunrise Labs said this week that it completed its succession plan, with president Eric Soederberg acquiring the majority of shares in the company through a stock sale with founder and board chair Drew Sunstein. With the transaction, the Bedford, N.H.-based company said that it secured its planned ownership […]
Abbott launches new CardioMems trial
Abbott (NYSE:ABT) said today it launched a new trial of its CardioMems HF implantable cardiac monitoring system, exploring the device’s ability to improve survival and quality of life for people with New York Heart Association Class II to Class IV heart failure. The study, dubbed the Guide-HF trial, is slated to enroll a total of 3,600 […]
Bigfoot brings Series B total to $55m with new investment from Abbott
Reeling in an $18 million add-on to the $37 million Series B that it reported last year, Bigfoot Biomedical touted today that it has raised over $90 million in total funding since the Milpitas, Calif.-based company first launched. Investments from Abbott (NYSE:ABT), which has an established partnership with Bigfoot, and other new and existing investors, brought the Series B round total […]
Abbott wins Japanese reimbursement nod for MitraClip
Abbott (NYSE:ABT) said today that it logged a reimbursement win in Japan for its MitraClip device for treating mitral valve regurgitation. The Chicago-area medtech giant said Japan’s Ministry of Health, Labor & Welfare granted national reimbursement for MitraClip, effective April 1. The MHLW approved the device last November for treating severe degenerative mitral regurgitation functional mitral regurgitation. […]
MIT study reveals the problem with bioresorbable stents
Bioresorbable coronary scaffolds, designed to avoid the risks associated with the long-term implantation of metal stents, once captured the attention of medtech giants like Abbott (NYSE:ABT) and Boston Scientific (NYSE:BSX). But companies have since linked the use of these biodegradable polymer-based devices to a heightened risk of myocardial infarction and thrombosis, prompting Abbott to pull its Absorb product from the […]
- 1
- 2
- 3
- …
- 59
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
Google+